GALLO, PAOLO
 Distribuzione geografica
Continente #
AS - Asia 2.300
NA - Nord America 146
EU - Europa 114
AF - Africa 1
OC - Oceania 1
SA - Sud America 1
Totale 2.563
Nazione #
SG - Singapore 2.187
US - Stati Uniti d'America 142
CN - Cina 47
HK - Hong Kong 46
IT - Italia 30
DE - Germania 23
CZ - Repubblica Ceca 19
GB - Regno Unito 13
FR - Francia 10
NL - Olanda 10
IN - India 8
PH - Filippine 5
FI - Finlandia 3
CA - Canada 2
JP - Giappone 2
LT - Lituania 2
MX - Messico 2
NO - Norvegia 2
AE - Emirati Arabi Uniti 1
AU - Australia 1
CY - Cipro 1
ES - Italia 1
ID - Indonesia 1
PE - Perù 1
PL - Polonia 1
SA - Arabia Saudita 1
TR - Turchia 1
ZA - Sudafrica 1
Totale 2.563
Città #
Hong Kong 45
Singapore 37
Ashburn 34
Boardman 25
Hefei 21
Brno 15
Rome 14
Munich 13
London 12
Shanghai 12
West Jordan 8
Los Angeles 6
Paris 6
Amsterdam 5
Bacolod City 4
Bengaluru 4
Council Bluffs 4
Olomouc 4
San Francisco 4
New York 3
Nuremberg 3
Pune 3
Washington 3
Aversa 2
Bologna 2
Caldogno 2
Dallas 2
Durham 2
Hamar 2
Hanover 2
Santa Clara 2
Seattle 2
Secaucus 2
Sona 2
The Dalles 2
Toronto 2
Turku 2
Zhoukou 2
Brooklyn 1
Buffalo 1
Chicago 1
Fuzhou 1
Guangzhou 1
Halfweg 1
Handan 1
Helsinki 1
Johannesburg 1
Lima 1
Melbourne 1
Mexico City 1
Mirabella Eclano 1
Nanchang 1
Newark 1
Nicosia 1
Riyadh 1
San Jose 1
Springfield 1
Stow 1
Suffern 1
Tokyo 1
Warsaw 1
Xi'an 1
Totale 339
Nome #
Takotsubo Syndrome and Coronary Artery Disease: Which Came First-The Chicken or the Egg? 192
Prediction of type 4a myocardial infarction with the angiography-derived hemodynamic (ADDED) index 186
Hepatic expression of lysosomal acid lipase is reduced in non-alcoholic fatty liver disease and inversely associated with the degree of microvescicular steatosis, impairment of the autophagic process and NAFLD activity score 183
Coronary Chronic Total Occlusion Revascularization: When, Who and How? 177
The hepatic expression of lysosomal acid lipase (LAL) is reduced in NAFLD patients, and associated with features of genetically determined LAL deficiency and NAFLD activity score 172
Detection of disability worsening in relapsing-remitting multiple sclerosis patients: a real-world roving Expanded Disability Status Scale reference analysis from the Italian Multiple Sclerosis Register 171
BREATH PRINT ANALYSIS BY E-NOSE IS ASSOCIATED WITH ADVERSE OUTCOMES OF CIRRHOTIC PATIENTS INDEPENDENTLY FROM THE OTHER PROGNOSTIC INDICES 170
Assessment of liver function by the exhaled breath-print during chronic liver disease 166
Glycaemic Control in Patients Undergoing Percutaneous Coronary Intervention: What Is the Role for the Novel Antidiabetic Agents? A Comprehensive Review of Basic Science and Clinical Data 160
The Italian multiple sclerosis register 147
Relationship Between the Completeness of Revascularization and Myocardial Injury in Patients Treated With Percutaneous Coronary Intervention 145
THU-390 - Hepatic expression of lysosomal acid lipase is reduced in non-alcoholic fatty liver disease and inversely associated with the degree of microvescicular steatosis, impairment of the autophagic process and NAFLD activity score 121
Beyond the Calcium Score: What Additional Information from a CT Scan Can Assist in Cardiovascular Risk Assessment? 88
Impact of oral anticoagulant regimens on occurrence of contrast-induced nephropathy in patients undergoing coronary angioplasty 86
In situ electrostimulation drives a regenerative shift in the zone of infarcted myocardium 83
Relation of Platelet Indexes to Platelet Reactivity and Periprocedural Myocardial Infarction in Patients Who Underwent Percutaneous Coronary Angioplasty 76
Impact of burden and distribution of aortic valve calcification on the hemodynamic performance and procedural outcomes of a self-expanding, intra-annular transcatheter aortic valve system 74
LIVER TOXICITY IN COLORECTAL CANCER PATIENTS TREATED WITH FIRST LINE FOLFIRI-CONTAINING REGIMEN: A SINGLE INSTITUTION EXPERIENCE 68
Current Treatment Options for HCC: From Pharmacokinetics to Efficacy and Adverse Events in Liver Cirrhosis 67
Usefulness of Adding Pre-procedural Glycemia to the Mehran Score to Enhance Its Ability to Predict Contrast-induced Kidney Injury in Patients Undergoing Percutaneous Coronary Intervention Development and Validation of a Predictive Model 22
Hepatic complications of bariatric surgery : the reverse side of the coin 20
Totale 2.574
Categoria #
all - tutte 8.844
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.844


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202231 0 1 2 0 0 0 0 0 2 0 0 26
2022/202316 1 0 2 3 2 0 0 0 0 2 6 0
2023/2024119 2 3 5 8 5 23 2 7 16 16 15 17
2024/20252.404 22 5 31 10 15 25 27 1 40 110 1.046 1.072
2025/20264 4 0 0 0 0 0 0 0 0 0 0 0
Totale 2.574